Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02858180 · ClinicalTrials.gov registry record · Phase 4
Hepatitis C Virus(HCV) Heart and Lung Study
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT02858180 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 15 participants.
The verdict
NCT02858180, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is a multicenter study in Hepatitis C Virus (HCV) infected adult patients who also have advanced cardiac disease or advanced lung disease.
Interventions
- DRUG Sofosbuvir/ledipasvir fixed dose combination(SOF/LDV FDC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2016-12 |
| Est. Completion | 2019-07-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02858180
The ClinicalTrials.gov registry entry for NCT02858180 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sofosbuvir/ledipasvir fixed dose combination(SOF/LDV FDC) is the first listed.
NCT02858180 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02858180 about?
NCT02858180 is a clinical study titled "Hepatitis C Virus(HCV) Heart and Lung Study". This is a multicenter study in Hepatitis C Virus (HCV) infected adult patients who also have advanced cardiac disease or advanced lung disease.
What is the current status of trial NCT02858180?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2016-12. Estimated completion is 2019-07-04.
What interventions are being tested in trial NCT02858180?
The interventions under investigation include: Sofosbuvir/ledipasvir fixed dose combination(SOF/LDV FDC) (DRUG).
Who is sponsoring clinical trial NCT02858180?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.